APOB and metabolic syndrome: The apoB/apoA‐I ratio is considered to reflect the balance between atherogenic apoB‐containing particles and antiatherogenic high‐density lipoprotein particles.11 As such, this metric captures both dyslipidemia and dysmetabolic regulation.